Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma

British Journal of Cancer

Volumn 95, Issue 3, 2006, Pages 322-330

  Tsunoda, S ^a   Okumura, T ^a   Ito, T ^a   Mori, Y ^a   Soma, T ^a   Watanabe, G ^a   Kaganoi, J ^a   Itami, A ^a   Sakai, Y ^a   Shimada, Y ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Autocrine; Immunohistochemistry; NGF; Oesophageal cancer; p75NTR; TrkA

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CANCER CELL CULTURE; CANCER STAGING; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AUTOCRINE COMMUNICATION; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 33746873639     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603255     Document Type: Article

References (37)

1. Barbacid M (1995) Neurotrophic factors and their receptors. Curr Opin Cell Biol 7: 148-155
2. Bateman J, Van Vactor D (2001) The Trio family of guanine-nucleotide- exchange factors: regulators of axon guidance. J Cell Sci 114: 1973-1980
3. Combaret V, Gross N, Lasset C, Balmas K, Bouvier R, Frappaz D, Beretta-Brognara C, Philip T, Favrot MC, Coll JL (1997) Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression. Br J Cancer 75: 1151-1155
4. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Trope CG, Kristensen GB, Goscinski M, van de Putte G, Reich R (2001) Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clin Cancer Res 7: 3457-3464
5. Davidson B, Reich R, Lazarovici P, Ann Florenes V, Nielsen S, Nesland JM (2004) Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 83: 119-128
6. Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Trope CG, Florenes VA (2003) Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res 9: 2248-2259
7. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M (1996) The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc Natl Acad Sci USA 93: 5466-5471
8. Descamps S, Pawlowski V, Revillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP (2001a) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 61: 4337-4340
9. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H (2001b) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 276: 17864-17870
10. Dolle L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H (2003) Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 22: 5592-5601
11. Estrach S, Schmidt S, Diriong S, Penna A, Blangy A, Fort P, Debant A (2002) The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth. Curr Biol 12: 307-312
12. Geldof AA, Van Haarst EP, Newling DW (1998) Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis 1: 236-241
13. Isono K, Sato H, Nakayama K (1991) Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 48: 411-420
14. Ito T, Hashimoto Y, Tanaka E, Kan T, Tsunoda S, Sato F, Higashiyama M, Okumura T, Shimada Y (2006) An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 12: 1308-1316
15. Kauffman RF, Taylor RW, Pfeiffer DR (1980) Cation transport and specificity of ionomycin. Comparison with ionophore A23187 in rat liver mitochondria. J Biol Chem 255: 2735-2739
16. Kishibe K, Yamada Y, Ogawa K (2002) Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice. Gastroenterology 122: 1978-1986
17. Kramer K, Gerald W, LeSauteur L, Uri Saragovi H, Cheung NK (1996) Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. Clin Cancer Res 2: 1361-1367
18. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154-1162
19. Nakaji T, Kataoka TR, Watabe K, Nishiyama K, Nojima H, Shimada Y, Sato F, Matsushima H, Endo Y, Kuroda Y, Kitamura Y, Ito A, Maeda S (1999) A new member of the GTPase superfamily that is upregulated in highly metastatic cells. Cancer Lett 147: 139-147
20. Okumura T, Shimada Y, Imamura M, Yasumoto S (2003) Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 22: 4017-4026
21. Pflug BR, Dionne C, Kaplan DR, Lynch J, Djakiew D (1995) Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 136: 262-268
22. Pflug BR, Onoda M, Lynch JH, Djakiew D (1992) Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52: 5403-5406
23. Pincelli C, Marconi A (2000) Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 22: 71-79
24. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29
25. Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, Stec J, Stagliano NE, Ginsburg GS, Symmans WF, Pusztai L, Hortobagyi GN (2004) Targeted therapies for cancer 2004. Am J Clin Pathol 122: 598-609
26. Sakamoto Y, Kitajima Y, Edakuni G, Hamamoto T, Miyazaki K (2001a) Combined evaluation of NGF and p75NGFR expression is a biomarker for predicting prognosis in human invasive ductal breast carcinoma. Oncol Rep 8: 973-980
27. Sakamoto Y, Kitajima Y, Edakuni G, Sasatomi E, Mori M, Kitahara K, Miyazaki K (2001b) Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma. Oncol Rep 8: 477-484
28. Schneider MB, Standop J, Ulrich A, Wittel U, Friess H, Andren-Sandberg A, Pour PM (2001) Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer. J Histochem Cytochem 49: 1205-1210
29. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284
30. Sobin LH, Wittekind Ch (eds) (2002) TNM Classification of Malignant Tumours, 6th edn. John Wiley & Sons: New York
31. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24: 1217-1281
32. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85: 345-356
33. Walch ET, Marchetti D (1999) Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells. Clin Exp Metastasis 17: 307-314
34. Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT (2000) Rational basis for Trk inhibition therapy for prostate cancer. Prostate 45: 140-148
35. Zhu Z, Kleeff J, Kayed H, Wang L, Korc M, Buchler MW, Friess H (2002) Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog 35: 138-147
36. Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Buchler MW (2001) Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 7: 105-112
37. Zhu ZW, Friess H, Wang L, Di Mola FF, Zimmermann A, Buchler MW (2000) Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer. Anticancer Res 20: 125-132